University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...

A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret ...

New research presented at the 2025 International Kidney Cancer Symposium found that patients with localized renal cell ...

Findings are from the multicenter, prospective, Phase 3 STAMPEDE trial “Our findings suggest that the Decipher Prostate test may provide an important new tool to help guide treatment decisions for the ...

Researchers at the Johns Hopkins Kimmel Cancer Center, Johns Hopkins All Children's Hospital, and four other institutions have devised a novel method to test for prostate cancer using biomarkers ...

Doctors began testing PSA levels in the 1980s to monitor diagnosed cancers. By the early 1990s, researchers promoted it for ...

A three-year clinical trial seeks to find out if a simple blood test can detect cancer in senior citizens. The post Can a ...

Prostate cancer is the most common cancer in men, with about 1-in-8 expected to be diagnosed in their lifetime.

New study reveals most common cancer in the UK - The latest figures show that breast cancer is no longer the most common ...

Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, and University College London (UCL) today announced that data published online in Cell show that the Decipher Prostate Genomic ...